Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

The rash resolved after stopping ponatinib.

Tofacitinib may help treat hair loss in children with alopecia areata.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

JAK inhibitors may help improve symptoms in adults with APECED.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.